Clara Arozamena-Herrera
Madrid, MD 28006, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
New Tacrine Dimers Alleviate the Intracellular Amyloid-β-induced Cognitive Disturbance and Oxidative Stress in Mice.
Journal: Anais da Academia Brasileira de Ciencias
Published: July 30, 2025
Discovery of a potent melatonin-based inhibitor of quinone reductase-2 with neuroprotective and neurogenic properties.
Journal: European journal of medicinal chemistry
Published: June 12, 2024
Resveratrol-Based MTDLs to Stimulate Defensive and Regenerative Pathways and Block Early Events in Neurodegenerative Cascades.
Journal: Journal of medicinal chemistry
Published: March 04, 2022
Optical control of muscular nicotinic channels with azocuroniums, photoswitchable azobenzenes bearing two N-methyl-N-carbocyclic quaternary ammonium groups.
Journal: European journal of medicinal chemistry
Published: February 11, 2020
Identification of tetracyclic lactams as NMDA receptor antagonists with potential application in neurological disorders.
Journal: European journal of medicinal chemistry
Published: January 24, 2020
New flavonoid - N,N-dibenzyl(N-methyl)amine hybrids: Multi-target-directed agents for Alzheimer´s disease endowed with neurogenic properties.
Journal: Journal of enzyme inhibition and medicinal chemistry
Published: December 20, 2019
Tuning melatonin receptor subtype selectivity in oxadiazolone-based analogues: Discovery of QR2 ligands and NRF2 activators with neurogenic properties.
Journal: European journal of medicinal chemistry
Published: November 27, 2019
Neurogenic and neuroprotective donepezil-flavonoid hybrids with sigma-1 affinity and inhibition of key enzymes in Alzheimer's disease.
Journal: European journal of medicinal chemistry
Published: May 29, 2018
Optimization of Bicyclic Lactam Derivatives as NMDA Receptor Antagonists.
Journal: ChemMedChem
Published: January 18, 2017
Recent Advances in Neurogenic Small Molecules as Innovative Treatments for Neurodegenerative Diseases.
Journal: Molecules (Basel, Switzerland)
Published: June 09, 2016
New cinnamic - N-benzylpiperidine and cinnamic - N,N-dibenzyl(N-methyl)amine hybrids as Alzheimer-directed multitarget drugs with antioxidant, cholinergic, neuroprotective and neurogenic properties.
Journal: European journal of medicinal chemistry
Published: February 03, 2016
Novel N-Acetyl Bioisosteres of Melatonin: Melatonergic Receptor Pharmacology, Physicochemical Studies, and Phenotypic Assessment of Their Neurogenic Potential.
Journal: Journal of medicinal chemistry
Published: May 30, 2015
Last Updated: 09/26/2026